Antigen News and Research

RSS

Combining MRI and blood tests to avoid unnecessary prostate biopsies

MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests.

29 Mar 2024

Study reveals risk factors for faster aging in the brain

The researchers had previously identified a 'weak spot' in the brain, which is a specific network of higher-order regions that not only develop later during adolescence, but also show earlier degeneration in old age.

27 Mar 2024

Xenotransplantation model used for studying microglial response to Alzheimer's disease

Microglia are specialized immune cells in the brain. While they normally protect our brains, they can also contribute to neurodegenerative diseases such as Alzheimer's.

27 Mar 2024

Study reveals breakthrough in non-invasive detection of endometrial cancer

Study uncovers proteomic signatures in blood plasma and cervicovaginal fluid that could lead to non-invasive detection methods for endometrial cancer, demonstrating significant potential for early diagnosis and improved patient outcomes.

24 Mar 2024

Project PROTECTS launches to track acute respiratory infections across the United States

The City University of New York (CUNY) Institute for Implementation Science in Population Health (ISPH) and the CUNY Graduate School of Public Health and Health Policy (CUNY SPH), in collaboration with Pfizer, are initiating a critical two-year prospective epidemiologic study in the spring of 2024 to track acute respiratory infections across the United States.

22 Mar 2024

Rising survival rates for AML patients over 65 after allogeneic hematopoietic stem cell transplant

Among patients over 65 who received an allogeneic hematopoietic stem cell transplant (allo-HCT) for the treatment of acute myeloid leukemia (AML) between 2000 and 2021, leukemia-free and overall survival improved significantly over time.

22 Mar 2024

Concomitant pharmacotherapy overcomes immunotherapy challenges in aggressive blood cancer

Researchers at the University of Zurich and the University Hospital Zurich have discovered that a specific mutation in the cancer cells of an aggressive type of blood cancer can prevent novel immunotherapies such as CAR T-cell therapy from working.

21 Mar 2024

Astrocyte immune memory in multiple sclerosis pathology revealed

Immunological memory -; the ability to respond to a previously encountered antigen, or foreign substance, with greater speed and intensity on re-exposure is a hallmark of adaptive immunity.

20 Mar 2024

Unique bacteria colonize the gut shortly after birth and make serotonin to educate gut immune cells

A recent study revealed that neonatal gut bacteria produce serotonin and down-regulate monoamine oxidase A (MOA) to limit serotonin breakdown, thereby promoting immune tolerance.

20 Mar 2024

Immune cell protein identified as potential target for rare liver cancer treatment

Fibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The disease is caused by a single genetic mutation that creates a fusion protein.

20 Mar 2024

Rapid Novor and MAbSilico partner for world's first AI-guided epitope mapping service for antibodies

Rapid Novor and MAbSilico partner to provide the world's first comprehensive AI-guided epitope mapping service. This service combines hydrogen-deuterium exchange mass spectrometry (HDX-MS) with advanced artificial intelligence (AI)-driven computational modeling.

From Rapid Novor Inc 18 Mar 2024

Rare condition post-orgasmic illness syndrome explored in depth

Comprehensive review synthesizes current knowledge on post-orgasmic illness syndrome (POIS), a rare condition marked by a range of symptoms following ejaculation, highlighting the need for further research to understand its causes and develop effective treatments.

17 Mar 2024

Scientists aim to understand why T cells do not sustain energy in tumors

T cells are often called "assassins" or "killers" because they can orchestrate and carry out missions to hunt down bacteria, viruses, and cancer cells throughout the body.

15 Mar 2024

CHOP study uncovers metabolic key to faster immune response

Researchers from Children's Hospital of Philadelphia identified a key metabolite in cells that helps direct immune responses and explains at a single cell level why immune cells that most efficiently recognize pathogens, vaccines, or diseased cells grow and divide faster than other cells.

15 Mar 2024

DNA origami vaccine DoriVac paves way for personalized cancer immunotherapy

Therapeutic cancer vaccines are a form of immunotherapy in the making that could not only destroy cancer cells in patients, but keep a cancer from coming back and spreading.

15 Mar 2024

Innovative CAR T cell therapy targets two proteins to combat aggressive brain tumor growth

Breakthrough in Brain Cancer Treatment: Dual-Target CAR T Cell Therapy Shows Promise in Early Clinical Trial.

15 Mar 2024

Novel CAR-T therapy shows promising results in glioblastoma patients

A collaborative project to bring the promise of cell therapy to patients with a deadly form of brain cancer has shown dramatic results among the first patients to receive the novel treatment.

13 Mar 2024

Novel dual-target CAR T cell therapy shows promise in treating recurrent glioblastoma

Targeting two brain tumor-associated proteins-;rather than one-;with CAR T cell therapy shows promise as a strategy for reducing solid tumor growth in patients with recurrent glioblastoma (GBM), an aggressive form of brain cancer, according to early results from the first six patients treated in an ongoing Phase I clinical trial led by researchers from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine's Abramson Cancer Center.

13 Mar 2024

Major study reveals COVID vaccines protect against serious cardiac events post-infection

The impact of SARS-CoV-2 vaccination on thromboembolic and cardiovascular complication risk.

13 Mar 2024

Study highlights potential therapeutic target for immune-related disorders

A new study highlights a potential therapeutic target for immune-related disorders, such as multiple sclerosis and asthma.

11 Mar 2024

Antigen News and Research

Combining MRI and blood tests to avoid unnecessary prostate biopsies

Study reveals risk factors for faster aging in the brain

Xenotransplantation model used for studying microglial response to Alzheimer's disease

Study reveals breakthrough in non-invasive detection of endometrial cancer

Project PROTECTS launches to track acute respiratory infections across the United States

Rising survival rates for AML patients over 65 after allogeneic hematopoietic stem cell transplant

Concomitant pharmacotherapy overcomes immunotherapy challenges in aggressive blood cancer

Astrocyte immune memory in multiple sclerosis pathology revealed

Unique bacteria colonize the gut shortly after birth and make serotonin to educate gut immune cells

Immune cell protein identified as potential target for rare liver cancer treatment

Rapid Novor and MAbSilico partner for world's first AI-guided epitope mapping service for antibodies

Rare condition post-orgasmic illness syndrome explored in depth

Scientists aim to understand why T cells do not sustain energy in tumors

CHOP study uncovers metabolic key to faster immune response

DNA origami vaccine DoriVac paves way for personalized cancer immunotherapy

Innovative CAR T cell therapy targets two proteins to combat aggressive brain tumor growth

Novel CAR-T therapy shows promising results in glioblastoma patients

Novel dual-target CAR T cell therapy shows promise in treating recurrent glioblastoma

Major study reveals COVID vaccines protect against serious cardiac events post-infection

Study highlights potential therapeutic target for immune-related disorders

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News